Indonesia Requires AI Trace QR Codes on Supplements

Indonesia’s Food and Drug Supervisory Agency, BPOM, put Regulation HK.02.02.3.55526 into effect on June 28, 2026, introducing a new labeling requirement for dietary supplement products sold in the Indonesian market when AI has been used to assist ingredient ratio design or process parameter optimization. The change matters beyond packaging alone: it reaches formulation records, label control, product release, and export coordination, especially for manufacturers and brand owners supplying protein powders, vitamin gummies, probiotic freeze-dried tablets, and related ready-to-consume supplement products into Indonesia.

What the rule now requires

Based on the confirmed information provided, the new BPOM rule took effect on June 28, 2026 under reference HK.02.02.3.55526. It applies to Dietary Suppl products sold in Indonesia, including products such as protein powder, vitamin gummies, and probiotic freeze-dried tablets. Where AI has been used to support raw material ratio formulation or process parameter optimization, the product package must carry a unique AI formulation traceability QR code. That code must link to a blockchain evidence platform certified by BPOM. The provided information also states that Chinese contract manufacturers must upgrade their label management systems accordingly.

Where the operational impact is likely to appear first

For product owners and exporters selling into Indonesia

From an industry perspective, these companies are likely to be affected because market access is now tied not only to product composition and labeling content, but also to whether AI-assisted formulation activity can be reflected in a package-level traceability mechanism. The immediate pressure point is likely to be export compliance coordination: companies will need to confirm whether AI was used in formulation or process optimization, whether the affected SKU falls within the regulated product scope, and whether packaging released for Indonesia includes the required QR code linked to the specified traceability pathway.

For contract manufacturers handling formula development and packaging

Manufacturing sites may be affected most directly where they participate in recipe design, process adjustment, or final label issuance. The provided information specifically points to Chinese OEM and contract manufacturing facilities needing to upgrade label management systems. Analysis shows that this is not only a packaging change but also a document-control issue, because the packaging output must stay aligned with how the formula or process was developed and how that development is recorded for the Indonesian market.

For procurement and supply chain coordination teams

Procurement and supply chain teams may feel the change through SKU separation, packaging version control, and release planning. Observably, if one market requires a unique AI formulation traceability code while another does not, procurement and delivery workflows may need closer review to avoid mixed packaging, shipment delays, or relabeling at a late stage. What deserves closer attention is the handoff between formulation teams, packaging suppliers, and export documentation teams.

For compliance, certification, and traceability service functions

Compliance-related teams are likely to be affected because the rule connects packaging, traceability, and a BPOM-certified blockchain evidence platform. Even without further execution detail in the provided information, companies involved in regulatory review, labeling approval, or traceability support will need to monitor how records, review standards, and submission expectations are interpreted in practice.

What companies should review now

Check how AI use is identified internally

Analysis shows that a practical first step is to clarify which products actually fall into the AI-assisted category described in the rule. Companies will need an internal basis for determining whether AI was used in ingredient ratio work or process parameter optimization, because that determination appears to trigger the packaging obligation.

Revisit label control and packaging release workflows

What deserves closer attention is whether existing label approval systems can manage unique QR code requirements for Indonesia-bound products. For manufacturers already producing multiple market versions, the operational risk may sit in version control, artwork approval, and release timing rather than in formula design alone.

Prepare supporting records for traceability alignment

Observably, businesses should review whether their technical and compliance files can support the link between AI-assisted development activity and the QR code placed on-pack. The provided information does not define the full documentation set, so this should be treated as a monitoring and readiness issue rather than as a completed checklist.

Watch for follow-on execution language

Because the input does not provide detailed enforcement procedures, companies should continue tracking official wording, implementation interpretations, and any downstream changes in customer specifications or import-facing document requests. This is especially relevant for exporters and OEM suppliers serving Indonesian buyers under fixed delivery windows.

Why this looks like an execution signal, not just a policy headline

Analysis shows that the most notable feature of this development is the combination of AI-assisted formulation, mandatory package marking, and linkage to a certified blockchain evidence platform. That makes the development more than a general discussion about AI in product development. It is more appropriate to understand this as a concrete compliance signal for products already entering or circulating in the Indonesian supplement market, while also recognizing that some execution details still require further observation.

How the market may need to read this change

At this stage, the update is best understood as a live regulatory requirement with direct implications for labeling control, export coordination, and traceability preparation in the dietary supplement supply chain. The confirmed facts support a clear compliance reading, but the market should remain measured about downstream effects until more detailed implementation practice, review standards, and business-side feedback become visible.

Basis of this article

This article is based on the user-provided news title, event date, and event summary concerning BPOM Regulation HK.02.02.3.55526 taking effect on June 28, 2026. For developments of this kind, relevant source types typically include official regulator notices, regulatory agency releases, trade or customs authority information, industry association updates, standards-related documents, and reporting by authoritative sector media. No specific official source link was provided in the input, so the exact official link still needs to be verified on an ongoing basis. It also remains necessary to monitor later details such as implementation guidance, certification interpretation, tender or buyer document changes, industry feedback, and actual company execution practices.